Stocks to Trade
Eli Lilly and Company (LLY) intends to increase sales of immunological illness medications
Despite certain hiccups, advanced treatment maker Eli Lilly and Company (NYSE: LLY) intends to increase sales of its immunological illness medications. The FDA expressed concerns